论文部分内容阅读
目的分析腹膜透析联合血液透析治疗慢性肾衰竭的临床疗效。方法 50例慢性肾衰竭患者,随机分成对照组及实验组,各25例。对照组患者给予腹膜透析治疗,实验组患者给予腹膜透析联合血液透析治疗,比较两组患者的临床疗效。结果治疗前,两组患者的肌酐、尿素氮、血红蛋白、白蛋白水平比较,差异均无统计学意义(P>0.05);治疗后,两组患者的肌酐、尿素氮、血红蛋白、白蛋白水平均较本组治疗前改善,且实验组改善程度优于对照组,差异均具有统计学意义(P<0.05)。实验组患者并发症发生率8.0%低于对照组32.0%,差异具有统计学意义(χ~2=4.50,P<0.05)。结论在对慢性肾衰竭患者进行治疗时,腹膜透析联合血液透析治疗能显著改善患者尿素氮、肌酐等指标,同时显著降低并发症发生率,具有临床推广和应用价值。
Objective To analyze the clinical effects of peritoneal dialysis combined with hemodialysis in the treatment of chronic renal failure. Methods 50 cases of chronic renal failure patients were randomly divided into control group and experimental group, 25 cases each. Patients in the control group were treated with peritoneal dialysis, patients in the experimental group were treated with peritoneal dialysis combined with hemodialysis, and the clinical efficacy was compared between the two groups. Results Before treatment, the levels of creatinine, urea nitrogen, hemoglobin and albumin in the two groups had no significant difference (P> 0.05). After treatment, the levels of creatinine, urea nitrogen, hemoglobin and albumin Compared with the control group, the improvement in the experimental group was better than that in the control group, and the differences were statistically significant (P <0.05). The incidence of complication in experimental group was lower than that in control group by 8.0% (P <0.05), the difference was statistically significant (χ ~ 2 = 4.50, P <0.05). Conclusions Peritoneal dialysis combined with hemodialysis can significantly improve the indexes of urea nitrogen and creatinine in patients with chronic renal failure and significantly reduce the incidence of complications, which is of clinical promotion and application value.